Latest Capital Markets News

Page 11 of 151
Tamboran Resources has reported record gas flow rates from its Shenandoah South 6H well and secured US$188 million in a capital raise, positioning the company to deliver first gas in the Beetaloo Basin by Q3 2026.
Maxwell Dee
Maxwell Dee
14 May 2026
Novo Resources narrowed its Q1 2026 net loss to CAD 685K, boosted cash to CAD 10.6M following a $5.9M placement, and outlined aggressive gold and antimony drilling campaigns in Australia.
Maxwell Dee
Maxwell Dee
14 May 2026
ASX has appointed Anthony Attia as its next Managing Director and CEO, bringing nearly 30 years of global exchange experience to guide the company through its ongoing transformation.
Claire Turing
Claire Turing
14 May 2026
Finder Energy (ASX:FDR) is advancing its KTJ Project in Timor-Leste, aiming for a final investment decision by mid-2026 and first oil production by late 2027. Ownership of the Petrojarl I FPSO and strategic alliances underpin a fast-tracked development with forecast production of up to 30,000 barrels per day.
Maxwell Dee
Maxwell Dee
13 May 2026
Atlas Arteria reported a resilient 2025 with 9.3% EBITDA growth and steady toll revenue, while its Board unanimously urged investors to reject IFM’s unsolicited takeover offer, citing undervaluation and onerous conditions.
Nora Hopper
Nora Hopper
13 May 2026
Titomic Limited is set to shift its corporate domicile from Australia to the United States through a scheme of arrangement, aiming to deepen its US defense market presence and access broader capital pools while maintaining its ASX listing.
Victor Sage
Victor Sage
13 May 2026
Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.
Ada Torres
Ada Torres
13 May 2026
5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.
Maxwell Dee
Maxwell Dee
13 May 2026
Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.
Ada Torres
Ada Torres
12 May 2026
GreenTech Metals has raised $7.5 million through an oversubscribed placement to accelerate exploration and development at its Munni Munni and Whundo projects in Western Australia's West Pilbara.
Maxwell Dee
Maxwell Dee
12 May 2026
Almonty Industries reported a 221% jump in Q1 2026 revenue to CAD 25.4 million, driven by soaring tungsten prices and ramp-up at its Sangdong Mine, while net loss narrowed to CAD 5.3 million amid strong operational cash flow.
Maxwell Dee
Maxwell Dee
12 May 2026
EBR Systems accelerated its U.S. commercial rollout of the WiSE CRT System in Q1 2026 with implant volumes more than doubling and revenue hitting US$2.4 million. The company also secured a key regulatory milestone in Australia with TGA Priority Review, yet losses deepened and cash burn intensified, raising fresh questions about its funding runway.
Ada Torres
Ada Torres
12 May 2026